The Team Strategies for Overcoming Challenges to Guideline-Concordant Care of High-Risk HR-Positive/HER2-Negative Early Breast Cancer workshop is scheduled for Wednesday, July 22, 2026, from 8:00 AM to 9:00 AM Eastern Time (ET) as a virtual event, hosted by the private host group NC in Hendersonville, North Carolina, United States.

Led by faculty presenter Jame Abraham, MD, FACP (Enterprise Chairman, Department of Hematology and Medical Oncology and Professor of Medicine at Cleveland Clinic), this multidisciplinary workshop will provide practical insights into optimizing care for patients with high-risk HR-positive/HER2-negative early breast cancer. The session is designed to meet the educational needs of oncologists, nurse practitioners, physician associates, oncology nurses, pharmacists, and other healthcare professionals by focusing on identifying patients eligible for adjuvant CDK4/6 inhibitors, aligning treatment decisions with NCCN Guidelines and pivotal trial data, and personalizing therapy based on clinical and patient-specific factors.

Register Now.